| Objective Through a randomized, controlled trial design,Iobserved Fei-shu acupoint application in the treatment of hepatic hydrothorax(Triple Energizer congestion, Lung failure declared.)to make sure the clinical curative effects and the security.As a result,we try to provide the basis and technical operation specification for the use of Feishu acupoint sticking plaster external treatment of the disease.Methods The research on the patients with hepatic hydrothorax,and liver disease course of disease associated with pulmonary infection, TCM Syndrome Differentiation for the triple energizer congestion, Lung Qi obstruction syndrome patients as the research object. All cases were derived from Hubei Provincial Chinese Traditional Medical Hospital Department of Liver Departments at March 2014- December 2014. A total of 30 cases.They were randomly divided into two groups by using the SPSS19.0:The group of Fei Shu plaster acupoint application and the control group of Feishu plaster simulation agent each in 15 cases. Test group: basic treatment of Western medicine + Feishu plaster(mainly consists of musk, borneol, camphor and other traditional Chinese medicine composition) external spreads in the bilateral lung Yu Xue, one times/day, each applicator for 16 hours, daily changing medicine,continuous use for 2 weeks. Control group: On the basis of Western conventional treatment only, continuous use for 2 weeks.After treatment, the overall effect was observed before and after treatment, clinical, clinical symptom scores change, the maximum diameter of pleural fluid level changes, changes in liver function,etc., efficacy analysis; observe the occurrence of adverse events and blood, urine, feces, ECG indexes and renal function safety evaluationResults ①Clinical comparison of the overall efficacy of the two groups: the total efficiency of treatment group is 86.67% while the effectiveness of the control group with Feishu p laster simulation agentotal is 73.33%, Feishu plaster acupoint application group was better than that of Feishu plaster simula tion agent control group; There were significant difference bet ween two groups(P<0. O5).②Changes in clinical symptom scores compare: TCM symptoms before treatment groups total points, the difference was not statistically significant(P> 0.05), compar able; After treatment, the TCM symptoms total score were better than before treatment, comparison between the two groups obser vation group total score reduced symptoms significantly, and be tter than the control group, the difference was statistically s ignificant(t =-4.687, P = 0.000), explain the observation gro up than the control group in terms of total points to improve s ymptoms. Before treatment, patients were cough, sputum, chest p ain, breathlessness, chest tightness, urination, abdominal dist ension, nausea, dizziness, red eyes, loose stools or constipati on and other symptoms scores, the difference was not statistica lly significant(P> 0.05), comparable; after treatment, comparison between the two groups, the observation group in cough, spu tum, chest tightness, breathlessness, urination and other sympt oms significantly reduced integration, and better than the cont rol group, the difference was statistically significant( t =-2.232, P = 0.034; t =-2.259, P = 0.032; t =-2.2274, P = 0.031;t =-2.200, P = 0.036)); but chest pain, bloating, fatigue, an orexia, fever and other symptoms scores, the difference was not statistically significant(P> 0.05). Tips to improve the obser vation group were cough, sputum, chest tightness, breathlessnes s, urination aspect better than the control group; in improving patient chest pain, abdominal distension, nausea, dizziness, r ed eyes, loose stools or constipation no significant effect.③C omparison of two groups of patients with maximum diameter varia tion pleural fluid level: before treatment, pleural fluid level two largest diameter, the difference was not statistically sig nificant(P> 0.05), comparable; after treatment, both groups ha d the largest reduction in the diameter of pleural fluid level but more significantly reduce the observation group, the differ ence was statistically significant(t =-2.259, P = 0.032), exp lain the test group in terms of reduction of pleural effusion e ffective than the control group.The difference was statisticall y significant(P<O.05). It indicates that the treatment group i n reducing the pleural effusion is better than the control grou p.④Hepatic Detection index: After treatment, the of group FEI-SHU Cupuncture points plaster application on ALB, ALP, ALT, AS T index is obviously better than that the contrast group of Fei shu plaster simulation(P<0.05). GGT, TBIL have no significant d ifference, and no statistically significant difference betweengroups(P>0.05). No significant difference before and after the rest of the virus index, indexes of liver fibrosis, B ultrasou nd size diameter of portal vein and spleen thickness treatment(P>0.05).⑤The whole research is successful except 2 patients s uffer the skin irritation of skin damage, manifested as adverse reaction of pruritus, erythema, dry, may be related with the i ndividual constitution sensitive. Through topical inunction of lincomycin hydrochloride and lidocaine hydrochloride and Anerdi an external coating after symptoms continue treatment did not a ppear again adverse reactions aggravate. The remaining patients except one patient treated before check urine occult blood 1+,the rest of the patients showed no obvious abnormal changes af ter treatment, blood, urine routine test review.Through the who le treatment,we have contionous relationshio with the observer s.Conclusion Feishu acupoint application in the treatment of hepatic hydrothorax(Triple Energizer congestion, Lung Qi obstruction syndrome) has obvious curative effect. On the basis of Western conventional treatment, The use of Feishu plaster can not only improve the symptoms of cough in patients with Cough, sputum,chest tightness, shortness of breath, urination, decrease compared to the baseline liver function index obviously, and also has certain auxiliary therapeutic effect for primary disease. At the same time,Feishu plaster has a non-toxic side effects, safety and good compliance.It enriches the liver disease treatment and the treatment method is suitable for clinical application. So,it is worth to further study and discussion. |
PDF Full Text Request